Timothy Lu
Vermögen: 153 869 $ am 31.05.2026
Vermögen: 153 869 $ am 31.05.2026
Timothy K.
Lu is the founder of Corvium, Inc. (2009) serving as Director; Synlogic Operating Co., Inc. (2014); Eligo Bioscience SA (2014); BiomX Ltd. (2015); Senti Sub I, Inc. (2016) serving as Chief Executive Officer & Director; Engine Biosciences Pte Ltd. (2016) serving as Director & Chairman-Scientific Advisory Board; Senti Biosciences, Inc. (2016) serving as Chief Executive Officer & Director; Tango Therapeutics Sub, Inc. (2017); Tango Therapeutics, Inc. (2017); and Synlogic, Inc. (2017).
Current jobs include Chief Executive Officer & Director at Senti Biosciences Holdings, Inc. starting 2026; Director at Alliance for Regenerative Medicine; Director at Provectus Algae Pty Ltd. since 2021; and Advisor at Nest.Bio Ventures.
Former job includes Scientific Advisor at AmpliPhi Biosciences Corp.
from 2017 to 2019.
Education includes doctorate from Massachusetts Institute of Technology, undergraduate degree in 2003 and graduate degree in 2007 from Massachusetts Institute of Technology, and doctorate from Harvard Medical School in 2010.
| Unternehmen | Datum | Anzahl der Aktien | Bewertung | Datum der Bewertung |
|---|---|---|---|---|
0,52 % | 27.03.2026 | 161 627 ( 0,52 % ) | 153 869 $ | 31.05.2026 |
| Unternehmen | Position | Beginn |
|---|---|---|
Corvium, Inc.
Corvium, Inc. Packaged SoftwareTechnology Services Develops food risk intelligence solutions | Gründer | 01.03.2009 |
Synlogic Operating Co., Inc.
Synlogic Operating Co., Inc. Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company | Gründer | 01.01.2014 |
Engine Biosciences Pte Ltd.
Engine Biosciences Pte Ltd. BiotechnologyHealth Technology Develops novel combinations of genes and drugs for therapeutic and industrial purposes | Gründer | 01.01.2016 |
Senti Sub I, Inc.
Senti Sub I, Inc. BiotechnologyHealth Technology Develops novel therapeutics | Gründer | 01.01.2016 |
Provectus Algae Pty Ltd.
Provectus Algae Pty Ltd. BiotechnologyHealth Technology Operates as biotechnology products | Direktor/Vorstandsmitglied | 23.03.2021 |
Senti Biosciences, Inc.
Senti Biosciences, Inc. BiotechnologyHealth Technology Develops a synthetic biology platform that enables to program next-generation cell and gene therapies | Gründer | 09.06.2016 |
Alliance for Regenerative Medicine
Alliance for Regenerative Medicine Medical/Nursing ServicesHealth Services Promotes legislative, regulatory and reimbursement initiatives for regenerative medicine | Direktor/Vorstandsmitglied | - |
Nest.Bio Ventures
Nest.Bio Ventures Investment ManagersFinance Nest.Bio invests in companies located in the United States. The firm focuses on companies operating in the field of life science sector. It provides financing for early-stage capital requirements. | Berater | - |
| Unternehmen | Position | Ende |
|---|---|---|
| TANGO THERAPEUTICS, INC. | Gründer | 01.01.2021 |
| ░░░░░░░░ ░░░░░░░░░░░ ░░░░░ | ░░░░░░░ | ░░░░░░░░░░ |
| ░░░░░ ░░░░ | ░░░░░░░░ | ░░░░░░░░░░ |
| ░░░░░░░░░ ░░░░ | ░░░░░░░░ | - |
| ░░░░░ ░░░░░░░░░░░░ ░░░░ ░░░░ | ░░░░░░░░ | - |
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
| Private Unternehmen | 16 |
|---|---|
AmpliPhi Biosciences Corp.
AmpliPhi Biosciences Corp. BiotechnologyHealth Technology Develops and commercializes novel bacteriophage-based therapeutics | Health Technology |
Massachusetts Institute of Technology
Massachusetts Institute of Technology Finance/Rental/LeasingFinance Functions as a College/University | Finance |
Harvard Medical School
Harvard Medical School Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Alliance for Regenerative Medicine
Alliance for Regenerative Medicine Medical/Nursing ServicesHealth Services Promotes legislative, regulatory and reimbursement initiatives for regenerative medicine | Health Services |
Corvium, Inc.
Corvium, Inc. Packaged SoftwareTechnology Services Develops food risk intelligence solutions | Technology Services |
Synlogic Operating Co., Inc.
Synlogic Operating Co., Inc. Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company | Health Technology |
Eligo Bioscience SA
Eligo Bioscience SA Miscellaneous Commercial ServicesCommercial Services Operates as a proprietary platform to edit the microbiome gene repertoire | Commercial Services |
Senti Sub I, Inc.
Senti Sub I, Inc. BiotechnologyHealth Technology Develops novel therapeutics | Health Technology |
Tango Therapeutics Sub, Inc.
Tango Therapeutics Sub, Inc. BiotechnologyHealth Technology Develops transformational new drugs for cancer patients | Health Technology |
BiomX Ltd.
BiomX Ltd. Pharmaceuticals: MajorHealth Technology Develops drugs for cancer treatment | Health Technology |
Synlogic, Inc.
Synlogic, Inc. BiotechnologyHealth Technology Develops biopharmaceuticals | Health Technology |
Engine Biosciences Pte Ltd.
Engine Biosciences Pte Ltd. BiotechnologyHealth Technology Develops novel combinations of genes and drugs for therapeutic and industrial purposes | Health Technology |
Nest.Bio Ventures
Nest.Bio Ventures Investment ManagersFinance Nest.Bio invests in companies located in the United States. The firm focuses on companies operating in the field of life science sector. It provides financing for early-stage capital requirements. | Finance |
Provectus Algae Pty Ltd.
Provectus Algae Pty Ltd. BiotechnologyHealth Technology Operates as biotechnology products | Health Technology |
Tango Therapeutics, Inc.
Tango Therapeutics, Inc. BiotechnologyHealth Technology Operates as biotechnology company that engages in discovering and delivering precision cancer medicines | Health Technology |
Senti Biosciences, Inc.
Senti Biosciences, Inc. BiotechnologyHealth Technology Develops a synthetic biology platform that enables to program next-generation cell and gene therapies | Health Technology |
Bitte wählen Sie Ihre Ausgabe
Alle länderspezifischen Finanzinformationen